SCHEMBL16011808

SCHEMBL16011808

CC(C)CC(=O)C(=O)NC(Cc1ccc(-c2cccc(Cl)c2)cc1)CC(O)C(=O)O

nearest known ligand 0.77

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 18/20 0.77
▸ ACE P12821 9/20 0.77
▸ MMEL1 Q495T6 4/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16008124 1.00 MME (0.77) MMEACEMMEL1
SCHEMBL16008239 0.90 MME (0.80) MMEACEMMEL1
SCHEMBL14890447 0.87 MME (1.00) MMEACEMMEL1
SCHEMBL18597868 0.87 MME (1.00) MMEACEMMEL1
SCHEMBL16011679 0.87 MME (0.78) MMEACEMMEL1
SCHEMBL16008688 0.87 MME (0.78) MMEACEMMEL1
SCHEMBL16011723 0.85 MME (0.73) MMEACEMMEL1
SCHEMBL16008428 0.85 MME (0.73) MMEACEMMEL1
SCHEMBL18597964 0.85 MME (0.79) MMEACEMMEL1
SCHEMBL14890436 0.85 MME (0.79) MMEACEMMEL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2964616-A1 NEPRILYSIN INHIBITORS Theravance Biopharma R&D IP, LLC (US) 2016-01-13 — — EP disclosed
WO-2014138053-A1 NEPRILYSIN INHIBITORS THERAVANCE BIOPHARMA R&D IP, LLC (US) 2014-09-12 — — WO disclosed
Send feedback